Pooled Testing for Expanding COVID-19 Mass Surveillance.

Global efforts to control the spread of SARS-CoV-2 have relied heavily on diagnostic testing. However, many regions face limitations in testing capacity. Existing methods require individual sample testing, which can be resource-intensive. Pooled testing has been used historically in blood banks to increase efficiency. This approach reduces the number of tests needed by combining multiple samples into a single test. Positive results trigger individual follow-up testing. Prior research has shown pooled testing can maintain diagnostic accuracy. Recent studies have explored its application for SARS-CoV-2. This gap motivated investigations into optimal pooling strategies.

This work aimed to assess the feasibility of pooled testing for SARS-CoV-2 in large-scale surveillance. The specific problem is limited testing capacity in pandemic-affected regions. The motivation is to expand diagnostic reach without increasing resource demands. The study focused on determining optimal pool sizes and techniques. It sought to confirm whether pooled testing can maintain diagnostic accuracy. Researchers also aimed to evaluate compatibility with existing equipment and personnel. The goal is to provide a scalable solution for mass testing. This approach could support population-wide screening efforts.

Researchers analyzed pooled testing protocols using PCR-based diagnostics. They evaluated different pool sizes, including up to 32 and 64 samples per pool. Additional PCR amplification cycles were tested to maintain sensitivity. Simulations were conducted to model optimal pooling strategies. Experimental validation was performed in multiple countries, including the U.S., Israel, and Germany. Data were collected on detection accuracy and resource requirements. The methods included both theoretical modeling and practical implementation. Findings were compared to individual testing benchmarks.

Pooled testing detected positive samples in pools of up to 32 with 96% sensitivity. Some studies extended this to pools of 64 with additional PCR cycles. Simulation models identified optimal pool sizes based on prevalence rates. The number of tests required decreased significantly with pooled approaches. No significant loss in diagnostic accuracy was observed. Equipment and personnel requirements remained compatible with existing systems. Results confirmed pooled testing’s feasibility for large-scale use. These findings suggest it can support expanded surveillance efforts.

The authors propose that pooled testing can maintain diagnostic accuracy for SARS-CoV-2. They suggest it is a viable strategy for expanding testing capacity in resource-limited settings. The findings indicate compatibility with existing PCR equipment and personnel. They propose that pooled testing reduces the number of tests needed for mass screening. The authors suggest it can be used effectively in population-wide surveillance programs. They propose that additional PCR cycles may be necessary for larger pools. The authors suggest that pooled testing is a practical solution for pandemic control. They propose that it can be implemented without requiring new infrastructure.